Medical Search

Medical News from FDA US Food & Drug

FDA warns of potential contamination in multiple brands of drugs, dietary supplements

August 11, 2017, 12:34 pm by FDA US Food & Drug

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.


Featured Medical Stories

Newest Fitbits

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Sense Sleep Tracker

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from FDA US Food & Drug

Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico
FDA US Food & Drug : October 20, 2017, 7:19 am
Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico

FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma
FDA US Food & Drug : October 18, 2017, 2:37 am
The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL).

California dietary supplement maker, Custompax prohibited from manufacturing
FDA US Food & Drug : October 13, 2017, 9:14 am
A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in a consent decree.

Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico
FDA US Food & Drug : October 13, 2017, 5:31 am
Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico

FDA clears new robotically-assisted surgical device for adult patients
FDA US Food & Drug : October 13, 2017, 1:14 am
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.